JOHNSON & JOHNSON — Director's Dealing 2016

May 6, 2016

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2016-04-28

Reporting Person: Duato Joaquin (Exec VP, WW Chair, Pharma)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	47960.0000	Direct
Common Stock	538.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$58.3300	2019-02-08	Common Stock (34288.0000)		Direct
Employee Stock Options (Right to Buy)	$61.7500	2018-02-10	Common Stock (20842.0000)		Direct
Employee Stock Options (Right to Buy)	$62.2000	2021-01-08	Common Stock (19293.0000)		Direct
Employee Stock Options (Right to Buy)	$65.3700	2022-01-17	Common Stock (100000.0000)		Direct
Employee Stock Options (Right to Buy)	$72.5400	2023-01-13	Common Stock (148538.0000)		Direct
Employee Stock Options (Right to Buy)	$90.4400	2024-02-09	Common Stock (130969.0000)		Direct
Employee Stock Options (Right to Buy)	$100.0600	2025-02-09	Common Stock (126369.0000)		Direct
Employee Stock Options (Right to Buy)	$101.8700	2026-02-08	Common Stock (125824.0000)		Direct
Restricted Share Units	$		Common Stock (9049.0000)		Direct
Restricted Share Units	$		Common Stock (9812.0000)		Direct
Restricted Share Units	$		Common Stock (8919.0000)		Direct

Footnotes

F1: Shares held in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan.

F2: Vested and exercisable one day after the third anniversary of the date of the grant.

F3: Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.